Company intelligence / Profile preview

DawnLight

Palo Alto, California, United Statesdawnlight.fr ↗

Ownership: Private
Development stage: Commercial

Overview

DawnLight provides an AI-driven ambient intelligence platform that uses continuous sensor data to deliver real-time health insights, aiming to improve patient outcomes and reduce healthcare costs. The company has filed patents related to remote health monitoring systems targeting sleep disorders and psychiatric diagnosis. In Asia, affiliated entities develop functional drinks and supplements with biotech applications.

Therapeutic areas: OtherPsychiatryNeurology
Modalities: DeviceDiagnostic radiopharmaceutical preparationsFunctional foods and supplements
Industry: Digital Health Medical Devices

Partnerships

StartX Med COVID Task Force coalition

Beyond the preview

Go deeper on DawnLight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DawnLight.

Explore the full profile